Test Directory
| Test Code | |||||
| NMOIG | |||||
| Test Name | |||||
| NMO IgG Autoantibodies | |||||
| CPT Codes | |||||
| 86051 | |||||
| Expected Turnaround Time | |||||
| 3 - 5 days | |||||
| Clinical Utility | |||||
|
Establishing the diagnosis of neuromyelitis optica (NMO) and related disorders, including relapsing transverse myelitis or relapsing optic neuritis. Distinguishing NMO and NMO spectrum disorders from multiple sclerosis early in the course of disease. This test can also be used to trigger initiation and monitor effectiveness of therapy. |
|||||
| Specimen and Container Info | |||||
|
Specimen Type: Serum Collection Container: Gold Top, Serum Separator Alternate Collection Container: Red Top, Plain
Desired Specimen Volume: 0.2 mL |
|||||
| Collection Instructions | |||||
|
|||||
| Processing and Submission Instructions | |||||
|
|||||
| Transport Instructions | |||||
|
Transport to the laboratory refrigerated. |
|||||
| Stability Requirements | |||||
|
|||||
| Methodology | |||||
| ELISA | |||||
| Reference Intervals | |||||
|
See patient report. |
|||||
| Limitations | |||||
|
Seronegativity does not exclude the diagnosis of NMO.1 Immunosuppressive therapy may result in negative results. |
|||||
| Alternate Names | |||||
|
|||||
| Reference Lab | |||||
| Labcorp Of America Holdings | |||||
| Testing Schedule | |||||
| Routine, 3 times per week | |||||
The American Medical Association (AMA) Current Procedural Terminology (CPT) codes published by HNL Lab Medicine are guidelines and are intended for informational purposes only. CPT coding is the exclusive responsibility of the billing entity. View the Terms.
© 2026 HNL Lab Medicine. All rights reserved.